Stock CELC CELCUITY INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Celcuity Inc.

Equities

CELC

US15102K1007

Market Closed - Nasdaq
Other stock markets
 21:00:00 21/06/2024 BST 		5-day change 1st Jan Change
15.93 USD +2.31% Intraday chart for Celcuity Inc. +5.99% +9.33%
05-31 Needham Trims Price Target on Celcuity to $23 From $24, Maintains Buy Rating MT
05-30 Sector Update: Health Care Stocks Mixed Pre-Bell Thursday MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Celcuity To Participate in Jefferies Global Healthcare Conference
AQ
Needham Trims Price Target on Celcuity to $23 From $24, Maintains Buy Rating
MT
Sector Update: Health Care Stocks Mixed Pre-Bell Thursday
MT
Celcuity Plans Phase 3 Trial of Potential Breast Cancer Therapy, Receives Additional Term Loan
MT
Celcuity Prices $60 Million Common Stock Offering
MT
Celcuity Announces Pricing of Underwritten Common Stock Offering
AQ
Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line Treatment for HR+/HER2- Advanced Breast Cancer and Secures Approximately $62 Million Debt Financing
AQ
Celcuity Inc. Announces Plan to Initiate A Phase 3 Clinical Trial for Gedatolisib as First-Line Treatment for HR+/HER2- Advanced Breast Cancer
CI
Craig-Hallum Adjusts Price Target on Celcuity to $27 From $25, Assumes Buy Rating
MT
Celcuity Q1 Net Loss Widens; Shares Rise After Hours
MT
Celcuity Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Transcript : Celcuity Inc., Q1 2024 Earnings Call, May 15, 2024
Celcuity Inc. Reports First Quarter Financial Results and Provides Corporate Update
AQ
Celcuity Inc. Schedules Release of First Quarter 2024 Financial Results and Webcast/Conference Call
AQ
Celcuity To Present at Upcoming Needham and Stifel Investor Conferences
AQ
Celcuity Inc. Enters into Second Amendment to its Existing Loan and Security Agreement
CI
Craig Hallum Adjusts Celcuity Price Target to $25 From $20, Maintains Buy Rating
MT
Needham Adjusts Price Target on Celcuity to $24 From $23, Keeps Buy Rating
MT
Transcript : Celcuity Inc., Q4 2023 Earnings Call, Mar 27, 2024
Celcuity Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CELC Stock
  4. News Celcuity Inc.